Literature DB >> 32859814

Impact of Prolonged Lockdown due to COVID-19 in Patients with Parkinson's Disease.

Shweta Prasad1, Vikram Venkappayya Holla2, Koti Neeraja2, Bharath Kumar Surisetti2, Nitish Kamble2, Ravi Yadav2, Pramod Kumar Pal2.   

Abstract

BACKGROUND: The COVID-19 pandemic has compelled countries to impose lockdowns to curb the spread. As a result of the lockdown and need for health care services to cater to acute diseases on priority, patients with chronic illnesses such as Parkinson's disease (PD) may be facing several difficulties. AIMS: This study aimed to explore the effects of prolongation of lockdown on patients with PD by evaluating possible problems faced during a lockdown and worsening of symptoms if any.
MATERIALS AND METHODS: One hundred patients with PD and their caregivers were contacted.
RESULTS: We observed a significant increase in problems faced due to this pandemic, specifically, the inability to access health care, and difficulty procuring medication. Patients also reported worsening of motor symptoms.
CONCLUSIONS: The present findings highlight the need for health care systems to consider a plan of action for chronic neurological diseases like PD, which are worsening in the absence of regular hospital visits.

Entities:  

Keywords:  COVID-19; Coronavirus; Parkinson's disease; lockdown

Mesh:

Year:  2020        PMID: 32859814     DOI: 10.4103/0028-3886.293472

Source DB:  PubMed          Journal:  Neurol India        ISSN: 0028-3886            Impact factor:   2.117


  8 in total

1.  Prevalence and outcomes of Covid-19 in Parkinson's disease: Acute settings and hospital.

Authors:  Conor Fearon; Alfonso Fasano
Journal:  Int Rev Neurobiol       Date:  2022-04-20       Impact factor: 4.280

2.  Perception of COVID-19 Pandemic by Brazilian People With Parkinson's Disease and Multiple Sclerosis.

Authors:  Lucas Simieli; Felipe B Santinelli; Elisa C Costa; Marina H Kuroda; Lorena R Oliveira; Tiago Penedo; Julia Pilon; Aline P B Silveira; Iramaia S A Assis; Erica Tardelli; Erika Okamoto; Fabio A Barbieri
Journal:  Front Psychol       Date:  2022-05-19

3.  Parkinson's disease patients' needs during the COVID-19 pandemic in a red zone: A framework analysis of open-ended survey questions.

Authors:  Francesco Cavallieri; Francesca Sireci; Valentina Fioravanti; Giulia Toschi; Vittorio Rispoli; Francesca Antonelli; Massimo Costantini; Luca Ghirotto; Franco Valzania
Journal:  Eur J Neurol       Date:  2021-02-06       Impact factor: 6.288

4.  Teleneurorehabilitation Among Person with Parkinson's Disease in India: The Initial Experience and Barriers to Implementation.

Authors:  Divyani Garg; Ritu Majumdar; Sonal Chauhan; Ravi Preenja; Jasmine Parihar; Alvee Saluja; Rajinder K Dhamija
Journal:  Ann Indian Acad Neurol       Date:  2021-06-17       Impact factor: 1.383

5.  Effect of COVID-19 Related Lockdown on Nonmotor Symptoms of Parkinson's Disease.

Authors:  Sourav Banerjee; Adreesh Mukherjee; Kochupurackal P Mohanakumar; Atanu Biswas
Journal:  Ann Indian Acad Neurol       Date:  2021-04-21       Impact factor: 1.383

6.  Dementia and Mental Health During the COVID-19 Pandemic: A Systematic Review.

Authors:  Julia Mariano Gaigher; Isabel Barbeito Lacerda; Marcia Cristina Nascimento Dourado
Journal:  Front Psychiatry       Date:  2022-07-07       Impact factor: 5.435

Review 7.  Barriers to Accessing Healthcare Services for People with Parkinson's Disease: A Scoping Review.

Authors:  Muhammed Shahriar Zaman; Setareh Ghahari; Mary Ann McColl
Journal:  J Parkinsons Dis       Date:  2021       Impact factor: 5.568

8.  Impact of the COVID-19 Pandemic on Patients with Parkinson's Disease from the Perspective of Treating Physicians-A Nationwide Cross-Sectional Study.

Authors:  Andreas Wolfgang Wolff; Bernhard Haller; Antonia Franziska Demleitner; Erica Westenberg; Paul Lingor
Journal:  Brain Sci       Date:  2022-03-05
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.